Register Login

DBV TECHNOLOGIES SA (DBVT)

(85% Positive) DBV TECHNOLOGIES SA (DBVT) Announces Enrollment Update for results Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot March 26, 2026, 9:26 p.m.

    📋 DBV TECHNOLOGIES SA (DBVT) - Clinical Trial Update

    Filing Date: 2026-03-26

    Accepted: 2026-03-26 17:25:26

    Event Type: Clinical Trial Update

    Event Details:

    DBV TECHNOLOGIES SA (DBVT) Announces Clinical Trial Update DBV TECHNOLOGIES SA (DBVT) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: results, Patch
    • Collaboration: Financial Results and
    • Updated Timeline: December 31, 2025, the full year 2025
      • anticipated in the first half of 2026
      • anticipated in the second half of 2026

    🔬 Clinical Development Pipeline (DBV TECHNOLOGIES SA):

    Product Type Development Stage Therapeutic Area Source
    Epicutaneous Immunotherapy BIOLOGICAL Phase PHASE2 Peanut Allergy ClinicalTrials.gov
    Viaskin Peanut 250µg DRUG Phase PHASE3 Peanut Allergy ClinicalTrials.gov
    Placebo formulation BIOLOGICAL Phase PHASE1 Peanut Allergy ClinicalTrials.gov
    Whole peanut extract BIOLOGICAL Phase PHASE1 Peanut Allergy ClinicalTrials.gov
    Acadesine DRUG Phase PHASE1 Leukemia, B-Cell, Chronic ClinicalTrials.gov
    placebo of peanut BIOLOGICAL Phase PHASE2 Peanut Allergy ClinicalTrials.gov
    NT-KO-003 DRUG Phase PHASE2 Relapsing Remitting Multiple Sclerosis ClinicalTrials.gov
    ATH008 DRUG Phase PHASE2 Palmar-Plantar Erythrodysesthesia Syndrome ClinicalTrials.gov
    ACADESINE 315mg/kg/d DRUG Phase PHASE1 SMD ClinicalTrials.gov
    ACADESINE 210mg/kg/d DRUG Phase PHASE1 SMD ClinicalTrials.gov
    ACADESINE 140mg/kg/d DRUG Phase PHASE1 SMD ClinicalTrials.gov
    Methylphenidate MPH DRUG Phase PHASE1 Attention Deficit-Hyperactivity Disorder ClinicalTrials.gov
    Neurofeedback NFT DEVICE Phase PHASE1 Attention Deficit-Hyperactivity Disorder ClinicalTrials.gov
    Nutritional telemonitoring OTHER Approved Undernutrition ClinicalTrials.gov
    Boostrix™ BIOLOGICAL Phase PHASE1 Whooping Cough ClinicalTrials.gov
    Viaskin PT Placebo BIOLOGICAL Phase PHASE1 Whooping Cough ClinicalTrials.gov
    Viaskin PT 50 mcg BIOLOGICAL Phase PHASE1 Whooping Cough ClinicalTrials.gov
    Viaskin PT 25 mcg BIOLOGICAL Phase PHASE1 Whooping Cough ClinicalTrials.gov
    DBV712 IHRP DRUG Phase PHASE1 Peanut Allergy ClinicalTrials.gov
    GONDOLA AMPS DEVICE Approved Parkinson Disease ClinicalTrials.gov
    Viaskin Peanut DRUG Preclinical Peanut Allergy ClinicalTrials.gov
    Viaskin Peanut 250 mcg BIOLOGICAL Phase PHASE3 Peanut Allergy ClinicalTrials.gov
    Viaskin Peanut 100 mcg BIOLOGICAL Phase PHASE2 Peanut Allergy ClinicalTrials.gov
    Viaskin Peanut 50 mcg BIOLOGICAL Phase PHASE2 Peanut Allergy ClinicalTrials.gov
    PPG Smartwatch DEVICE Approved Paroxysmal Atrial Fibrillation ClinicalTrials.gov
    reSEES DEVICE Approved Intermediate AMD ClinicalTrials.gov
    DBV712 250 mcg BIOLOGICAL Phase PHASE3 Peanut Allergy ClinicalTrials.gov
    DBV712 DRUG Phase PHASE3 Allergy, Peanut ClinicalTrials.gov
    Viaskin Placebo DRUG Phase PHASE2 Eosinophilic Esophagitis ClinicalTrials.gov
    Viaskin Milk 500 mcg DRUG Phase PHASE2 Eosinophilic Esophagitis ClinicalTrials.gov
    Viaskin Milk 300 mcg BIOLOGICAL Phase PHASE1 Food Allergy ClinicalTrials.gov
    Viaskin Milk 150 mcg BIOLOGICAL Phase PHASE1 Food Allergy ClinicalTrials.gov
    Part B Placebo BIOLOGICAL Phase PHASE3 Peanut Allergy ClinicalTrials.gov
    Part B Viaskin Peanut 250 mcg BIOLOGICAL Phase PHASE3 Peanut Allergy ClinicalTrials.gov
    Part A Placebo BIOLOGICAL Phase PHASE3 Peanut Allergy ClinicalTrials.gov
    Part A Viaskin Peanut 100 mcg BIOLOGICAL Phase PHASE3 Peanut Allergy ClinicalTrials.gov
    Part A Viaskin Peanut 250 mcg BIOLOGICAL Phase PHASE3 Peanut Allergy ClinicalTrials.gov
    SURGICEL® Original DEVICE Approved Intraoperative Bleeding ClinicalTrials.gov
    GATT-Patch DEVICE Approved Intraoperative Bleeding ClinicalTrials.gov
    Placebo OTHER Phase PHASE3 Allergy, Peanut ClinicalTrials.gov
    Viaskin Peanut 250mcg BIOLOGICAL Phase PHASE3 Peanut Allergy ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: DBV TECHNOLOGIES SA
    • Ticker Symbol: DBVT

Search

News categories